483
Bioreliance CorporationFDA 483 - Bioreliance Corporation
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected BioReliance Corporation, a non-clinical laboratory in Rockville, MD, from August 6-8, 2019. The inspection revealed several deficiencies related to personnel training, responsibility assignment, material retention, and quality assurance unit oversight. These observations indicate a need for improved controls in the firm's operations.
- Company
- Bioreliance Corporation
- Product Type
- Biologics
Open in Dashboard
ID · b0edcd89-77c9-4465-990a-45d7a062c755